AustrAIHANZ – consensus guidelines on the investigation and management of autoimmune haemolytic anaemia in Australia and New Zealand

Autoimmune haemolytic anaemia is a rare immune‐mediated disorder leading to accelerated red cell destruction and anaemia. There is considerable clinical heterogeneity, with some patients barely requiring intervention, while others experience fulminant haemolysis and experience mortality rates as high as 30% with severe anaemia and end‐organ ischaemia. As there is insufficient high‐quality clinical data to guide management, we developed consensus practice statements based on Delphi methodology to provide clinicians with guidelines to approach diagnostic investigations, initiation of therapy, second‐line treatment options, supportive care and pregnant patients.